SciRhom
Latest round
- Series A
Last raised
- Jun 2024
Total raised
- $67M
Investors
- 11
About SciRhom
SciRhom GmbH, founded in 2016 in Planegg, Germany, specializes in creating therapeutic antibodies targeting iRhom2, an upstream regulator of TACE.SciRhom GmbH develops innovative therapeutic antibodies specifically targeting iRhom2, a key regulator of inflammatory signaling through TACE. Their leading products are first-in-class humanized antibodies aimed at reducing inflammatory responses associated with conditions like rheumatoid arthritis, inflammatory bowel disease, and lupus nephritis.SciRhom GmbH generates revenue through strategic partnerships and licensing agreements within the biopharmaceutical industry, focusing on the development and commercialization of its anti-iRhom2 therapeutic antibodies. The company aims to expand its product offerings by launching new therapeutic antibodies and targeting additional markets in North America and Europe by 2025.
Who invested in SciRhom
11 investors across 1 round
See all investors in SciRhom
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 26, 2024
Amount
$67M
Investors
Questions about SciRhom
Who invested in SciRhom?
SciRhom has 11 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SciRhom raised?
SciRhom has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did SciRhom last raise money?
SciRhom's most recent round on record is a Series A, in Jun 2024.
What does SciRhom do?
SciRhom GmbH, founded in 2016 in Planegg, Germany, specializes in creating therapeutic antibodies targeting iRhom2, an upstream regulator of TACE.
Where is SciRhom headquartered?
SciRhom is headquartered in Planegg, Germany.
Which VCs invest in companies like SciRhom?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at SciRhom's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like SciRhom? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.